ArticleOncotarget2016

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

Christian B Schiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.